Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04586387 · ClinicalTrials.gov registry record · NA
The Effect of Brain Anatomy on the Efficacy of Brain Stimulation Therapy
A NA study, sponsored by Virginia Commonwealth University.
- Completed
- Registry status
- NA
- Development phase
- 12
- Enrollment target
NCT04586387: Completed NA study, sponsored by Virginia Commonwealth University.
NCT04586387 is a NA study that has completed, run by Virginia Commonwealth University. The registered enrollment target is 12 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04586387, a NA study, has completed, sponsored by Virginia Commonwealth University.
- COMPLETED
- Registry status
- NA
- Development phase
- 12 participants
- Enrollment target
Study Summary
The purpose of this research study is to determine whether brain anatomy impacts the efficacy of transcranial magnetic stimulation (TMS) which is a form of non-invasive brain stimulation. TMS is used to stimulate different areas of the brain and it is well tolerated and generally a safe procedure. It has been studied by researchers for 20 plus years. This brain stimulation device and technique used in this study is an investigational device that has not been approved by the U.S. FDA for treating any muscle or nerve problems. A copy of the device brochure can be found at: https://www.magstim.com/product/rapid-family/
Primary Outcome
The amplitude the motor evoked potentials (MEPS) will be used to determine level of corticomotor excitability
Interventions
- DEVICE intermittent theta burst stimulation (iTBS) with sham and then active stimulation over bicep muscle
- DEVICE intermittent theta burst stimulation (iTBS) with sham and then active stimulation over finger muscle
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2020-11-09 |
| Est. Completion | 2022-07-08 |
| Phase | NA |
What the finished NCT04586387 record still lists
NCT04586387 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 12 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 2 interventions - of which intermittent theta burst stimulation (iTBS) with sham and then active stimulation over bicep muscle is the first listed.
NCT04586387 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04586387 about?
NCT04586387 is a clinical study titled "The Effect of Brain Anatomy on the Efficacy of Brain Stimulation Therapy". The purpose of this research study is to determine whether brain anatomy impacts the efficacy of transcranial magnetic stimulation (TMS) which is a form of non-invasive brain stimulation. TMS is used to stimulate different areas of the brain and it is well tolerated and generally a safe procedure. I...
What is the current status of trial NCT04586387?
This trial is currently completed. It is a NA study. The enrollment target is 12 participants. The study started on 2020-11-09. Estimated completion is 2022-07-08.
What interventions are being tested in trial NCT04586387?
The interventions under investigation include: intermittent theta burst stimulation (iTBS) with sham and then active stimulation over bicep muscle (DEVICE), intermittent theta burst stimulation (iTBS) with sham and then active stimulation over finger muscle (DEVICE).
Who is sponsoring clinical trial NCT04586387?
This trial is sponsored by Virginia Commonwealth University, which has 558 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04586387's enrollment target sits among peer trials
12 1913th of 2000 higher than 74 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02602769 · 12 participants
Whole Transcriptome Profiling and Metabolic Phenotyping in Children With ROHHAD Syndrome
- NCT02605421 · 12 participants · Phase 2
Myeloablative Consolidation Therapy and Tandem Autologous Stem Cell Rescue in Patients With High-Risk Neuroblastoma
- NCT02619448 · 12 participants · Early Phase 1
Concurrent Chemotherapy Plus HFR Radiation Therapy in Inoperable NSCLC
- NCT03311503 · 12 participants · Phase 1
Phase I/II Trial of Lentiviral Gene Transfer for SCID-X1 With Low Dose Targeted Busulfan Conditioning
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI